HIV-1 coreceptors CCR5 and CXCR4 both mediate neuronal cell death but CCR5 paradoxically can also contribute to protection

被引:0
|
作者
M Kaul
Q Ma
K E Medders
M K Desai
S A Lipton
机构
[1] Center for Neuroscience and Aging,Department of Blood and Marrow Transplantation
[2] Burnham Institute for Medical Research,undefined
[3] Center for Blood Research,undefined
[4] Harvard Medical School,undefined
[5] M.D. Anderson Cancer Center,undefined
来源
关键词
HIV-1-associated dementia; neuroAIDS; neurodegeneration; apoptosis; immune activation; macrophages/microglia; HIV/gp120; chemokine receptors; CCR5; CXCR4; MIP-1; RANTES; knockout;
D O I
暂无
中图分类号
学科分类号
摘要
The chemokine receptors CCR5 and CXCR4 serve, in addition to CD4, as coreceptors for human immunodeficiency virus-1 (HIV-1), and infection with HIV-1 can cause dementia. In brain-derived cells, HIV-1 envelope glycoprotein gp120 initiates a signaling cascade that involves p38 mitogen-activated protein kinase and leads to neuronal cell death. Using mixed neuronal/glial cultures from rats and mice genetically deficient in one or both HIV coreceptors, we show here that CCR5, CXCR4 or both can mediate HIV/gp120 neurotoxicity depending on the viral strain. Paradoxically, we also found evidence for a CCR5-mediated neuroprotective pathway. We identify protein kinase Akt/PKB as an essential component of this pathway, which can be triggered by the CCR5 agonists macrophage inflammatory protein-1β and regulated-and-normal-T-cell-expressed-and-secreted. Moreover, these CCR5 ligands prevent neuronal cell death induced by stromal cell-derived factor-1, a CXCR4 agonist. Both neurons and glia coexpress CXCR4 and CCR5. Ca2+ imaging experiments demonstrate that engagement of CCR5 prevents CXCR4-triggered increases in intracellular free Ca2+. This finding suggests that CCR5 ligands can protect neurons at least, in part, by modulating CXCR4-mediated toxicity through heterologous desensitization.
引用
收藏
页码:296 / 305
页数:9
相关论文
共 50 条
  • [31] Localization of HIV-1 co-receptors CCR5 and CXCR4 in the brain of children with AIDS
    Vallat, AV
    De Girolami, U
    He, JL
    Mhashilkar, A
    Marasco, W
    Shi, B
    Gray, F
    Bell, J
    Keohane, C
    Smith, TW
    Gabuzda, D
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 1998, 152 (01): : 167 - 178
  • [32] Linkages between HIV-1 specificity for CCR5 or CXCR4 and in vitro usage of alternative coreceptors during progressive HIV-1 subtype C infection
    Cashin, Kieran
    Jakobsen, Martin R.
    Sterjovski, Jasminka
    Roche, Michael
    Ellett, Anne
    Flynn, Jacqueline K.
    Borm, Katharina
    Gouillou, Maelenn
    Churchill, Melissa J.
    Gorry, Paul R.
    [J]. RETROVIROLOGY, 2013, 10
  • [33] Signal transduction due to HIV-1 envelope interactions with chemokine receptors CXCR4 or CCR5
    Davis, CB
    Dikic, I
    Unutmaz, D
    Hill, CM
    Arthos, J
    Siani, MA
    Thompson, DA
    Schlessinger, J
    Littman, DR
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (10): : 1793 - 1798
  • [34] CCR5 HIV-1 vertical transmission
    Shearer, WT
    Kalish, LA
    Zimmerman, PA
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1998, 17 (02): : 180 - 181
  • [35] CCR5 and CXCR4 antagonist and agonist binding sites
    Teintze, Martin
    Wilkinson, Royce
    Grieco, Paul
    Mills, John
    Dratz, Edward
    [J]. RETROVIROLOGY, 2006, 3
  • [36] CCR5 and CXCR4 antagonist and agonist binding sites
    Martin Teintze
    Royce Wilkinson
    Paul Grieco
    John Mills
    Edward Dratz
    [J]. Retrovirology, 3 (Suppl 1)
  • [37] CCR5 inhibitors in HIV-1 therapy
    Dorr, Patrick
    Perros, Manos
    [J]. EXPERT OPINION ON DRUG DISCOVERY, 2008, 3 (11) : 1345 - 1361
  • [38] Owl monkey CCR5 reveals synergism between CD4 and CCR5 in HIV-1 entry
    Nahabedian, John
    Sharma, Amit
    Kaczmarek, Maryska E.
    Wilkerson, Greg K.
    Sawyer, Sara L.
    Overbaugh, Julie
    [J]. VIROLOGY, 2017, 512 : 180 - 186
  • [39] CCR5 cell surface density and HIV-1 envelope sequences govern antiretroviral potency of CCR5 antagonists
    Miller, MD
    Lineberger, JE
    Dornadula, G
    Danzeisen, RC
    Blau, CR
    Danovich, RM
    Miller, MA
    Finke, PE
    Oates, BD
    Caldwell, CG
    Chen, P
    Meurer, LC
    Mills, SG
    Springer, MS
    Petropoulos, CJ
    Whitcomb, J
    Huang, W
    Fransen, S
    Simon, AJ
    Hazuda, DJ
    [J]. ANTIVIRAL THERAPY, 2003, 8 (03) : U66 - U67
  • [40] CCR5 and CXCR4 coreceptors may not be responsible for conferment of resistance to HIV exposed but seronegative individuals of Nigerian origin
    Ibeh, B. O.
    Obidoa, O.
    Uzoegwu, P.
    [J]. FEBS JOURNAL, 2012, 279 : 108 - 108